Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Watch video Digital event video 18 April 2023, 13:00 - 14:30 CEST Developing a high-quality research proposal - The FIP Foundation and ECPG Grant for Professional Innovation More This webinar will provide all necessary information for the FIP Foundation and ECPG Grant for Professional innovation and and guide applicants on how to make the application stronger and more competitive by improving their research proposal
Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment
We Are Here to Help You To learn more, check out our full list of FAQs To learn more, check out our full list of FAQs What does GHK-Cu do
From then on, I felt well taken care of, Cindy said
After Takeda lost exclusivity of Vyvanse last year, the FDA approved generic versions of Vyvanse from 11 drugmakers, including U.S.-based drugmakers Mallinckrodt and Viatris, UK-based Hikma Pharmaceuticals and Indian drugmaker Sun Pharmaceutical Industries, Reuters reported
139 , 370372, doi: 10.1164/ajrccm/139.2.370 (1989)
US$ 24.11
US$ 21.74
US$ 26.99
US$ 24.10
US$ 21.44
US$ 23.71
